Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - alfuzosin hydrochloride -

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - alfuzosin hydrochloride - tablets - 2.5mg milligram

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - alfuzosin hydrochloride 2.5mg;   - film coated tablet - 2.5 mg - active: alfuzosin hydrochloride 2.5mg   excipient: hypromellose lactose monohydrate macrogol stearate 400 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - alfuzosin hydrochloride 5mg;   - modified release tablet - 5 mg - active: alfuzosin hydrochloride 5mg   excipient: calcium hydrogen phosphate dihydrate hydrogenated castor oil hypromellose iron oxide red magnesium stearate microcrystalline cellulose povidone propylene glycol titanium dioxide

Israel - English - Ministry of Health

sanofi - aventis israel ltd - alfuzosin hydrochloride 2.5 mg - tablets - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy, notably when surgery has to be delayed for whaterver reason and during episodes of severe symptoms of adenoma, especially in elderly patients.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

alfuzosine 10mg

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

alfuzosin 10mg

Egypt - English - EDA (Egyptian Drug Authority)

sanofi aventis-france - coated tablet - 5 mg

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

bahrain pharmacy - alfuzosin hydrochloride - film coated tablet - 2.5

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

bahrain pharmacy - alfuzosin hydrochloride - prolonged-release tablets - 10